Injectable SN-38-embedded Polymeric Microparticles Promote Antitumor Efficacy against Malignant Glioma in an Animal Model

Malignant glioma (MG) is extremely aggressive and highly resistant to chemotherapeutic agents. Using electrospraying, the potent chemotherapeutic agent 7-ethyl-10-hydroxycamptothecia (SN-38) was embedded into 50:50 biodegradable poly[(<span style="font-variant: small-caps;">d,l</s...

Full description

Bibliographic Details
Main Authors: Yuan-Yun Tseng, Tao-Chieh Yang, Shu-Mei Chen, Shun-Tai Yang, Ya-Ling Tang, Shih-Jung Liu
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/12/5/479
_version_ 1797567125000290304
author Yuan-Yun Tseng
Tao-Chieh Yang
Shu-Mei Chen
Shun-Tai Yang
Ya-Ling Tang
Shih-Jung Liu
author_facet Yuan-Yun Tseng
Tao-Chieh Yang
Shu-Mei Chen
Shun-Tai Yang
Ya-Ling Tang
Shih-Jung Liu
author_sort Yuan-Yun Tseng
collection DOAJ
description Malignant glioma (MG) is extremely aggressive and highly resistant to chemotherapeutic agents. Using electrospraying, the potent chemotherapeutic agent 7-ethyl-10-hydroxycamptothecia (SN-38) was embedded into 50:50 biodegradable poly[(<span style="font-variant: small-caps;">d,l</span>)-lactide-<i>co</i>-glycolide] (PLGA) microparticles (SMPs). The SMPs were stereotactically injected into the brain parenchyma of healthy rats and intratumorally injected into F98 glioma-bearing rats for estimating the pharmacodynamics and therapeutic efficacy. SN-38 was rapidly released after injection and its local (brain tissue) concentration remained much higher than that in the blood for more than 8 weeks. Glioma-bearing rats were divided into three groups—group A (<i>n</i> = 13; stereotactically injected pure PLGA microparticles), group B (<i>n</i> = 12; stereotactically injected Gliadel wafer and oral temozolomide), and group C (<i>n</i> = 13; stereotactic and intratumoral introduction of SMPs). The SMPs exhibited significant therapeutic efficacy, with prolonged survival, retarded tumor growth, and attenuated malignancy. The experimental results demonstrated that SMPs provide an effective and potential strategy for the treatment of MG.
first_indexed 2024-03-10T19:37:18Z
format Article
id doaj.art-0486fc2f4eed43b989687b5ffa62edef
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T19:37:18Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-0486fc2f4eed43b989687b5ffa62edef2023-11-20T01:33:31ZengMDPI AGPharmaceutics1999-49232020-05-0112547910.3390/pharmaceutics12050479Injectable SN-38-embedded Polymeric Microparticles Promote Antitumor Efficacy against Malignant Glioma in an Animal ModelYuan-Yun Tseng0Tao-Chieh Yang1Shu-Mei Chen2Shun-Tai Yang3Ya-Ling Tang4Shih-Jung Liu5Division of Neurosurgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, Taipei 11031, TaiwanDepartment of Neurosurgery, Chung Shan Medical University Hospital, Taichung 40201, TaiwanDepartment of Neurosurgery, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, TaiwanDivision of Neurosurgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, Taipei 11031, TaiwanDepartment of Mechanical Engineering, Chang Gung University, Taoyuan 33302, TaiwanDepartment of Mechanical Engineering, Chang Gung University, Taoyuan 33302, TaiwanMalignant glioma (MG) is extremely aggressive and highly resistant to chemotherapeutic agents. Using electrospraying, the potent chemotherapeutic agent 7-ethyl-10-hydroxycamptothecia (SN-38) was embedded into 50:50 biodegradable poly[(<span style="font-variant: small-caps;">d,l</span>)-lactide-<i>co</i>-glycolide] (PLGA) microparticles (SMPs). The SMPs were stereotactically injected into the brain parenchyma of healthy rats and intratumorally injected into F98 glioma-bearing rats for estimating the pharmacodynamics and therapeutic efficacy. SN-38 was rapidly released after injection and its local (brain tissue) concentration remained much higher than that in the blood for more than 8 weeks. Glioma-bearing rats were divided into three groups—group A (<i>n</i> = 13; stereotactically injected pure PLGA microparticles), group B (<i>n</i> = 12; stereotactically injected Gliadel wafer and oral temozolomide), and group C (<i>n</i> = 13; stereotactic and intratumoral introduction of SMPs). The SMPs exhibited significant therapeutic efficacy, with prolonged survival, retarded tumor growth, and attenuated malignancy. The experimental results demonstrated that SMPs provide an effective and potential strategy for the treatment of MG.https://www.mdpi.com/1999-4923/12/5/479malignant glioma (MG)7-ethyl-10-hydroxycamptothecia (SN-38)irinotecan (CPT-11)poly(lactide-<i>co</i>-glycolide) (PLGA)intratumoral drug delivery
spellingShingle Yuan-Yun Tseng
Tao-Chieh Yang
Shu-Mei Chen
Shun-Tai Yang
Ya-Ling Tang
Shih-Jung Liu
Injectable SN-38-embedded Polymeric Microparticles Promote Antitumor Efficacy against Malignant Glioma in an Animal Model
Pharmaceutics
malignant glioma (MG)
7-ethyl-10-hydroxycamptothecia (SN-38)
irinotecan (CPT-11)
poly(lactide-<i>co</i>-glycolide) (PLGA)
intratumoral drug delivery
title Injectable SN-38-embedded Polymeric Microparticles Promote Antitumor Efficacy against Malignant Glioma in an Animal Model
title_full Injectable SN-38-embedded Polymeric Microparticles Promote Antitumor Efficacy against Malignant Glioma in an Animal Model
title_fullStr Injectable SN-38-embedded Polymeric Microparticles Promote Antitumor Efficacy against Malignant Glioma in an Animal Model
title_full_unstemmed Injectable SN-38-embedded Polymeric Microparticles Promote Antitumor Efficacy against Malignant Glioma in an Animal Model
title_short Injectable SN-38-embedded Polymeric Microparticles Promote Antitumor Efficacy against Malignant Glioma in an Animal Model
title_sort injectable sn 38 embedded polymeric microparticles promote antitumor efficacy against malignant glioma in an animal model
topic malignant glioma (MG)
7-ethyl-10-hydroxycamptothecia (SN-38)
irinotecan (CPT-11)
poly(lactide-<i>co</i>-glycolide) (PLGA)
intratumoral drug delivery
url https://www.mdpi.com/1999-4923/12/5/479
work_keys_str_mv AT yuanyuntseng injectablesn38embeddedpolymericmicroparticlespromoteantitumorefficacyagainstmalignantgliomainananimalmodel
AT taochiehyang injectablesn38embeddedpolymericmicroparticlespromoteantitumorefficacyagainstmalignantgliomainananimalmodel
AT shumeichen injectablesn38embeddedpolymericmicroparticlespromoteantitumorefficacyagainstmalignantgliomainananimalmodel
AT shuntaiyang injectablesn38embeddedpolymericmicroparticlespromoteantitumorefficacyagainstmalignantgliomainananimalmodel
AT yalingtang injectablesn38embeddedpolymericmicroparticlespromoteantitumorefficacyagainstmalignantgliomainananimalmodel
AT shihjungliu injectablesn38embeddedpolymericmicroparticlespromoteantitumorefficacyagainstmalignantgliomainananimalmodel